Townsend, W., Leong, S., Shah, M., Batten, T., Tucker, D., Pottinger, B., Paneesha, S., El-Sharkawi, D., Granger, D., O'Donovan, K., Nathwani, A., Jasani, P. (2025). Encouraging long-term efficacy and safety from first-in-human phase 1 study of time-limited NVG-111 in relapsed/refractory CLL and MCL. Blood. https://doi.org/10.1182/blood-2025-2125